BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23688812)

  • 1. Statistical assessment of proton treatment plans under setup and range uncertainties.
    Park PC; Cheung JP; Zhu XR; Lee AK; Sahoo N; Tucker SL; Liu W; Li H; Mohan R; Court LE; Dong L
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):1007-13. PubMed ID: 23688812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
    Shang H; Pu Y; Wang Y
    Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
    Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
    Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
    Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of dose-averaged linear energy transfer (LET
    Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
    Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments.
    den Otter LA; Kaza E; Kierkels RGJ; Meijers A; Ubbels FJF; Leach MO; Collins DJ; Langendijk JA; Knopf AC
    Med Phys; 2018 Dec; 45(12):5525-5534. PubMed ID: 30229930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
    Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Robustness to Setup and Range Uncertainties for Head and Neck Patients Treated With Pencil Beam Scanning Proton Therapy.
    Malyapa R; Lowe M; Bolsi A; Lomax AJ; Weber DC; Albertini F
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):154-162. PubMed ID: 27084638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
    Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.
    Koay EJ; Lege D; Mohan R; Komaki R; Cox JD; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1093-100. PubMed ID: 22543217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach.
    Moore JA; Gordon JJ; Anscher MS; Siebers JV
    Med Phys; 2009 Sep; 36(9):3880-90. PubMed ID: 19810460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.